Pool play has now ended! Below are the drugs that have advanced to the Round of 16, with a glimpse of how others voted. Congratulations to Edward Bornet, who correctly guessed the winners of 5 out of 8 groups! The tournament continues now into the Round of 16! Play along below to see the match ups and put in your picks.

Play Along Now! Round of 16
Surprised by any of the answers? See the actual RxScore for each of these drugs by registering for a complimentary 7 day trial of AdverseEvents Explorer!




Group A: Anticoagulants

Advances to Round of 16: Eliquis and Coumadin


group-A

See all RxScores

Group B: Type 2 Diabetes

Advances to Round of 16: Victoza and Onglyza


Group B

See all RxScores

Group C: Hepatitis C

Advances to Round of 16: Solvadi and Incivek


Group C

See all RxScores

Group D: Multiple Sclerosis

Advances to Round of 16: Tysabri and Gilenya


 Group D

See all RxScores

Group E: Statins

Advances to Round of 16: Crestor and Simcor


 Group E

See all RxScores

Group F: Antiplatelet

Advances to Round of 16: Plavix and Brilinta


 Group F

See all RxScores

Group G: Rheumatroid Arthritis

Advances to Round of 16: Enbrel and Xeljanz


 Group G

See all RxScores

Group H: Asthma

Advances to Round of 16: Advair Symbicort


 Group H

See all RxScores



 
Click here to play the round of 16


Jim Davis

Jim Davis

Executive Vice President

Jim Davis LinkedinJim Davis Twitter

 

Jim Davis

Written by Jim Davis

As Executive Vice President, Jim is responsible for the commercialization strategy for Advera Health Analytics.